Comparative preclinical biodistribution, dosimetry and endoradiotherapy in mCRPC of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T

被引：0
|
作者：
Yusufi, N. [1 ]
Nekolla, S. [1 ]
Wurzer, A. [2 ]
Herz, M. [1 ]
D'Alessandria, C. [1 ]
Weber, W. [1 ]
Wester, H. J. [2 ]
Eiber, M. [1 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany
[2] Tech Univ Munich, Chair Pharmaceut Radiopharm, Garching, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-274
引用
收藏
页码：S642 / S643
页数：2
相关论文
共 50 条
  • [31] Biodistribution and dosimetry of a single dose of [177Lu] Lu-DOTAZOL in patients with mCRPC
    Kramer, V.
    Fernandez, R.
    Lehnert, W.
    Flores, J.
    Soza-Ried, C.
    Ribbeck, J.
    Ceballos, M.
    Eppard, E.
    Jimenez-Franco, L.
    Kluge, A.
    Meckel, M.
    Roesch, F.
    Amaral, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S87 - S88
  • [32] PSMA Radioligand Therapy of Metastasized Prostate Cancer Using Lu-177 PSMA I&T and Lu-177 PSMA-617: First comparative Dosimetric Results
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Singh, A.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S36 - S37
  • [33] Identification of [177Lu]Lu-PSMA I&T, [177Lu]LuCl3 and [177Lu] Lu-DTPA by a single reversed-phase TLC
    Cucchi, C.
    Bogni, A.
    Mainente, M.
    Beretta, C.
    Kirienko, M.
    Seregni, E.
    Pascali, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S666 - S666
  • [34] Is 177Lu-PSMA an effective treatment modality for mCRPC patients with visceral metastasis?
    Gupta, Manoj
    Choudhury, Partha Sarathi
    Singh, Amitabh
    Rawal, Sudhir
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [35] Clinical dosimetry study of kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T
    Uijen, M.
    Prive, B.
    van Herpen, C.
    Gotthardt, M.
    Konijnenberg, M.
    Peters, S.
    Nagarajah, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S111 - S112
  • [36] Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T
    Gaeble, Alexander
    Dierks, Alexander
    Rinscheid, Andreas
    Patt, Marianne
    Wienand, Georgine
    Pfob, Christian H.
    Kircher, Malte
    Fukushima, Kazuhito
    Nikolic, Ana Antic
    Enke, Johanna S.
    Janzen, Tilman
    Steinestel, Julie
    Kempter, Hildegard
    Trepel, Martin
    Weckermann, Dorothea
    Lapa, Constantin
    Bundschuh, Ralph A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (03) : 970 - 978
  • [37] Is 177Lu-PSMA an effective treatment modality for mCRPC patients with visceral metastasis?
    Gupta, M.
    Choudhury, P. S.
    Singh, A.
    Rawal, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1 - S1
  • [38] Quantifying the impact of residual activity on therapeutic index: an updated dosimetric comparison between [177Lu]Lu-PSMA-10.1 and [177Lu]Lu-PSMA I&T
    Rinscheid, A.
    Dierks, A.
    Kircher, M.
    Pfob, C.
    Bundschuh, R. A.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S811 - S812
  • [39] Optimising the Synthesis and QC of [177Lu]Lu-PSMA I&T for Prostate Cancer Therapy
    Hong, K.
    Fincher, L.
    Browne, E.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 53 - 54
  • [40] Complete Resolution of Locally Advanced Prostate Cancer After Molecular Endoradiotherapy With 177Lu-PSMA
    Beheshti, Mohsen
    Vali, Reza
    Moghadam, Soroush Zarehparvar
    Amini, HamidReza
    Hakiminejad, Masoumeh
    Divband, GhasemAli
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : e276 - e277
12345